Trademark: 97632503
Word
ECR GLOBAL
Status Date
Thursday, June 27, 2024
Filing Date
Friday, October 14, 2022
Published for Opposition
Tuesday, October 17, 2023
35 Advertising relating to pharmaceutical products and in-vivo imaging products; Advertising services; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Rental of advertising space
The mark consists of the literal element "ECR Global" in stylized font along with a curved line above the letters "lobal".
ELIXIR CLINICAL RESEARCH GLOBAL
Color is not claimed as a feature of the mark.
"GLOBAL"
Oct 18, 2022
New Application Entered
Oct 31, 2022
New Application Office Supplied Data Entered
Nov 1, 2022
Notice Of Design Search Code E-Mailed
Jul 29, 2023
Assigned To Examiner
Aug 4, 2023
Priority Action Written
Aug 4, 2023
Priority Action E-Mailed
Aug 4, 2023
Notification Of Priority Action E-Mailed
Sep 12, 2023
Teas Response To Office Action Received
Sep 12, 2023
Correspondence Received In Law Office
Sep 13, 2023
Teas/Email Correspondence Entered
Sep 27, 2023
Notification Of Notice Of Publication E-Mailed
Oct 17, 2023
Published For Opposition
Oct 17, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 12, 2023
Noa E-Mailed - Sou Required From Applicant
May 20, 2024
Use Amendment Filed
May 20, 2024
Teas Statement Of Use Received
Jun 26, 2024
Case Assigned To Intent To Use Paralegal
Jun 27, 2024
Statement Of Use Processing Complete
Sep 14, 2023
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24
